##fileformat=VCFv4.2
##fileDate=20250407
##source=ScriptPython
##reference=GRCh37
##INFO=<ID=PHENOTYPE,Number=.,Type=String,Description="Disease phenotype">
##INFO=<ID=INTERPRETATION,Number=.,Type=String,Description="Variant interpretation">
##INFO=<ID=INTERPRETATION_REASON,Number=.,Type=String,Description="Reason for interpretation">
##INFO=<ID=CLINICAL_ACTIONABILITY,Number=.,Type=String,Description="Clinical actionability">
##INFO=<ID=GENE,Number=.,Type=String,Description="Gene symbol">
##INFO=<ID=VARIANT_ID,Number=1,Type=String,Description="Variant identifier">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
20	43042354	rs137853336T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853336T
20	43042354	rs137853336T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853336T
20	43042354	rs137853336T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853336T
20	43042354	rs137853336T	C	T	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853336T
20	43042354	rs137853336T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853336T
12	121426658	VCV003767145	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003767145
12	121426781	VCV003602126	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003602126
20	43052831	VCV003383937	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003383937
7	44189616	VCV003383919	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383919
20	43052876	VCV003370456	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003370456
12	121431496	VCV003358870	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003358870
12	121431490	VCV003338655	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003338655
12	121431433	VCV003238985	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003238985
12	121426703	VCV003238982	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003238982
20	43034710	VCV003238977	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238977
20	43048423	VCV003238974	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238974
20	43047064	VCV003238969	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238969
20	43047064	VCV003238969	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238969
20	43047064	VCV003238969	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238969
20	43047064	VCV003238969	G	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238969
20	43043273	VCV003238968	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238968
20	43042334	VCV003068530	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068530
20	43036105	VCV003068529	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068529
20	43036074	VCV003068527	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068527
20	43034847	VCV002736967	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002736967
12	121431472	VCV002691843	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691843
12	121431449	VCV002691841	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691841
12	121431442	VCV002691840	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691840
20	43052769	VCV002691836	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002691836
20	43043297	VCV002580600	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002580600
20	43036000	VCV002578346	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002578346
12	121426832	VCV002575051	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002575051
20	43052732	VCV002574173	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002574173
20	43043145	VCV002505491	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002505491
12	121426635	VCV001804170	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001804170
12	121434063	VCV001804169	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001804169
12	121426656	VCV001700671	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001700671
12	121426656	VCV001700671	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001700671
20	43048477	VCV001700660	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV001700660
12	121416898	rs2135820424A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820424A
12	121416898	rs2135820424C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820424C
12	121437125	rs749673816T	C	T	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs749673816T
12	121437125	rs749673816T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs749673816T
12	121437125	rs749673816T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs749673816T
12	121437125	rs749673816T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs749673816T
12	121437125	rs749673816T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs749673816T
12	121437193	rs2135850957A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135850957A
12	121431506	rs1555211935G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211935G
12	121431482	rs1057520779C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520779C
12	121431403	rs1180119907A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1180119907A
12	121416665	rs1388926124T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1388926124T
12	121416605	rs1275805852T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1275805852T
12	121416599	rs2135819400C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819400C
12	121416596	rs2135819387T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819387T
12	121416573	rs2135819325C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819325C
12	121416573	rs2135819325C	T	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819325C
12	121426781	rs2135832792T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832792T
12	121431403	rs1180119907T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1180119907T
12	121416891	rs2135820413G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820413G
12	121431505	rs2135839997G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135839997G
12	121431505	rs2135839997C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135839997C
12	121431481	rs769086289G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs769086289G
12	121426734	rs2135832668T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832668T
12	121431974	rs2135841104C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841104C
12	121431974	rs2135841104G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841104G
12	121426736	rs2135832685T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832685T
12	121426738	rs2135832689G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832689G
12	121432034	rs2135841592A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841592A
12	121416630	rs1566092362A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1566092362A
12	121431989	rs2135841224T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841224T
12	121416890	rs2135820404A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820404A
20	42984492	rs2146127862G	C	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146127862G
20	42984492	rs2146127862G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146127862G
20	42984447	rs2146127594A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146127594A
20	42984447	rs2146127594A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146127594A
20	42984264	rs2146126966A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146126966A
20	42984264	rs2146126966A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146126966A
20	43048381	rs376013528T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs376013528T
20	43048381	rs376013528T	C	T	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs376013528T
20	43048381	rs376013528T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs376013528T
20	43048381	rs376013528T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs376013528T
20	43042348	rs370239205T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs370239205T
7	44185186	rs2096271482T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096271482T
20	43042336	rs377476335A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs377476335A
20	43042336	rs377476335A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs377476335A
20	43042336	rs377476335A	G	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs377476335A
20	43042336	rs377476335A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs377476335A
20	43042336	rs377476335A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs377476335A
12	121426676	rs1876669134G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1876669134G
20	43052787	rs2063786151C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2063786151C
12	121434371	rs754729248A	C	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754729248A
20	43052757	rs369429452T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs369429452T
20	43047071	rs1775879070A	C	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1775879070A
12	121432001	rs1308016430T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1308016430T
12	121426652	rs1876667856T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1876667856T
12	121437431	rs1877324101A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1877324101A
12	121426836	rs1364708195A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1364708195A
12	121416731	rs766956862T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs766956862T
20	43052700	rs1191912908A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1191912908A
20	43048423	rs1290868034T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1290868034T
7	44189409	rs80356654G	A	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654G
7	44189409	rs80356654G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654G
7	44189409	rs80356654G	A	G	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654G
7	44189409	rs80356654G	A	G	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654G
20	43043303	rs1392795567A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1392795567A
20	43043303	rs1392795567A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1392795567A
12	121434064	rs1565886545C	G	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1565886545C
12	121434064	rs1565886545C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1565886545C
12	121426785	rs1172328722A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1172328722A
12	121426701	rs753998395A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs753998395A
12	121426701	rs753998395A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs753998395A
12	121426701	rs753998395A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs753998395A
12	121426701	rs753998395A	G	A	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs753998395A
12	121426701	rs753998395A	G	A	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs753998395A
12	121416590	rs1566092307T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1566092307T
12	121432040	rs771108132T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs771108132T
20	43042417	rs1555815158T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555815158T
12	121432065	rs779184183A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs779184183A
12	121432065	rs779184183A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs779184183A
12	121432065	rs779184183A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs779184183A
12	121431322	rs1555211904A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211904A
20	43052699	rs1555817727T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555817727T
20	43048382	rs1555816615A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555816615A
12	121432067	rs1555212014T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212014T
12	121432067	rs1555212014T	C	T	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212014T
12	121432067	rs1555212014T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212014T
12	121432067	rs1555212014T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212014T
12	121432067	rs1555212014T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212014T
12	121431416	rs1555211922A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211922A
12	121426743	rs1555211426T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211426T
7	44185236	rs556581174C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs556581174C
20	43048430	rs1555816654C	T	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555816654C
20	43048430	rs1555816654C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555816654C
20	43034848	rs1555813319A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555813319A
20	43034848	rs1555813319A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555813319A
20	43034848	rs1555813319A	G	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555813319A
20	43034848	rs1555813319A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555813319A
7	44193002	rs762263694A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs762263694A
7	44193002	rs762263694A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs762263694A
7	44193002	rs762263694A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs762263694A
12	121434371	rs754729248G	C	G	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754729248G
12	121434371	rs754729248G	C	G	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754729248G
12	121434371	rs754729248G	C	G	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754729248G
12	121426784	rs765432081T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs765432081T
12	121426784	rs765432081T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs765432081T
20	43042349	rs1085307913A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1085307913A
20	43042349	rs1085307913A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1085307913A
20	43042349	rs1085307913A	G	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1085307913A
20	43042349	rs1085307913A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1085307913A
7	44189576	rs1085307455A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1085307455A
7	44189576	rs1085307455A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1085307455A
7	44189576	rs1085307455A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1085307455A
7	44189576	rs1085307455A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1085307455A
7	44189576	rs1085307455A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1085307455A
12	121431481	rs769086289T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs769086289T
12	121431481	rs769086289T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs769086289T
12	121431481	rs769086289T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs769086289T
12	121431481	rs769086289T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs769086289T
12	121431481	rs769086289T	C	T	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs769086289T
7	44185262	rs1064793134T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064793134T
7	44192980	rs764232985T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs764232985T
7	44192980	rs764232985T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs764232985T
12	121431395	rs893256143A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs893256143A
12	121431395	rs893256143A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs893256143A
12	121431482	rs1057520779A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520779A
12	121431482	rs1057520779A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520779A
12	121432041	rs1057520504A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504A
12	121432041	rs1057520504A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504A
12	121432041	rs1057520504A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504A
12	121432041	rs1057520504A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504A
12	121432041	rs1057520504A	G	A	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504A
12	121432041	rs1057520504A	G	A	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504A
12	121426820	rs1057520291T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520291T
12	121426820	rs1057520291T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520291T
12	121426835	rs754728827T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754728827T
12	121426835	rs754728827T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754728827T
12	121426835	rs754728827T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754728827T
12	121426835	rs754728827T	C	T	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754728827T
12	121426835	rs754728827T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754728827T
12	121426835	rs754728827T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs754728827T
7	44189575	rs886042610T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs886042610T
12	121432032	rs886039544T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs886039544T
12	121432032	rs886039544T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs886039544T
12	121432064	rs886039386T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs886039386T
7	44187346	rs769268803T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs769268803T
7	44187346	rs769268803T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs769268803T
7	44187346	rs769268803T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs769268803T
7	44187346	rs769268803T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs769268803T
7	44185319	rs864321656A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs864321656A
20	43034835	rs587777732T	C	T	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs587777732T
20	43034835	rs587777732T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs587777732T
20	43034835	rs587777732T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs587777732T
20	43034835	rs587777732T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs587777732T
12	121431404	rs587780357A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587780357A
12	121431404	rs587780357A	G	A	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587780357A
7	44189603	rs587780345T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780345T
7	44189603	rs587780345T	C	T	.	PASS	PHENOTYPE=GESTATIONAL DIABETES;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780345T
7	44189603	rs587780345T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780345T
7	44189603	rs587780345T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780345T
7	44189603	rs587780345T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780345T
7	44189603	rs587780345T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780345T
7	44189624	rs587780344T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780344T
12	121432043	rs193922604T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922604T
12	121431394	rs193922598T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922598T
12	121431394	rs193922598T	C	T	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922598T
12	121431394	rs193922598T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922598T
12	121431394	rs193922598T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922598T
12	121431394	rs193922598T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922598T
20	43052756	rs193922479T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs193922479T
20	43052756	rs193922479T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs193922479T
7	44189362	rs148311934T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs148311934T
7	44189362	rs148311934T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs148311934T
7	44189362	rs148311934T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs148311934T
7	44189362	rs148311934T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs148311934T
7	44189362	rs148311934T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs148311934T
7	44184865	rs193922273T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922273T
12	121432080	rs137853245A	C	A	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853245A
12	121426700	rs137853244T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853244T
12	121426700	rs137853244T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853244T
12	121426644	rs137853243T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853243T
12	121426644	rs137853243T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853243T
12	121432068	rs137853238A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853238A
12	121432068	rs137853238A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853238A
12	121432068	rs137853238A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853238A
12	121426674	rs137853237G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853237G
12	121435307	rs137853236T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853236T
12	121435307	rs137853236T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853236T
12	121435307	rs137853236T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853236T
12	121435307	rs137853236T	C	T	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853236T
12	121435307	rs137853236T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853236T
20	43052883	rs137853338G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853338G
20	43042435	rs137853335T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853335T
12	121426836	VCV003767146	GT	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003767146
7	44192938	VCV003767143	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003767143
12	121426655	VCV003602129	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003602129
12	121426805	VCV003602128	T	TA	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003602128
12	121426807	VCV003602127	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003602127
12	121426769	VCV003602125	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003602125
12	121426670	VCV003602124	TC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003602124
20	43048424	VCV003602122	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003602122
20	43052864	VCV003602120	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003602120
7	44190583	VCV003602117	AAGG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003602117
7	44186071	VCV003602116	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003602116
20	43058202	VCV003393515	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003393515
7	44193063	VCV003393499	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003393499
7	44193064	VCV003393498	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003393498
20	43052889	VCV003383938	TG	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003383938
20	43052744	VCV003383936	C	CA	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003383936
12	121432023	VCV003383934	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003383934
7	44192000	VCV003383931	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383931
7	44191999	VCV003383930	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383930
7	44192001	VCV003383929	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383929
7	44192001	VCV003383928	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383928
7	44190614	VCV003383927	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383927
7	44187292	VCV003383926	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383926
7	44187291	VCV003383925	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383925
7	44187292	VCV003383924	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383924
7	44187291	VCV003383923	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383923
7	44185261	VCV003383915	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383915
7	44185201	VCV003383914	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383914
7	44192946	VCV003383913	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003383913
20	43052825	VCV003383754	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003383754
20	43052808	VCV003370457	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003370457
12	121431968	VCV003370452	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003370452
12	121438856	VCV003370444	TTGCCTCTGCAG	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=VCV003370444
20	43034798	VCV003358878	C	CG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003358878
20	43036051	VCV003358876	CAA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003358876
20	43034831	VCV003358874	CT	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003358874
12	121426724	VCV003358873	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003358873
12	121434441	VCV003358872	AC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003358872
12	121426648	VCV003358871	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003358871
20	43036066	VCV003340454	C	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003340454
20	43036066	VCV003340454	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003340454
7	44186200	VCV003338870	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003338870
12	121437431	VCV003338661	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003338661
12	121437431	VCV003338660	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003338660
12	121437194	VCV003338659	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003338659
12	121416637	VCV003338658	CAA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003338658
12	121438951	VCV003338657	ATC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=VCV003338657
12	121437285	VCV003338656	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003338656
7	44190674	VCV003338654	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003338654
7	44191868	VCV003256954	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003256954
7	44185183	VCV003250353	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003250353
7	44189588	VCV003238987	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003238987
7	44189588	VCV003238986	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003238986
12	121426704	VCV003238983	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003238983
12	121426699	VCV003238981	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003238981
12	121426697	VCV003238980	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003238980
20	42984446	VCV003238976	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238976
20	42984445	VCV003238975	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003238975
20	43052700	VCV003234008	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003234008
20	43052700	VCV003234003	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003234003
7	44189433	VCV003234002	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003234002
7	44185215	VCV003234000	AGC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003234000
7	44185192	VCV003233999	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233999
7	44185179	VCV003233997	GA	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233997
7	44185121	VCV003233996	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233996
7	44185121	VCV003233995	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233995
7	44185115	VCV003233994	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233994
7	44185115	VCV003233994	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233994
7	44185115	VCV003233994	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233994
7	44185115	VCV003233994	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233994
7	44190584	VCV003233993	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233993
7	44185114	VCV003233992	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233992
7	44184788	VCV003233991	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003233991
20	43034772	VCV003068533	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068533
20	43034772	VCV003068533	G	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068533
20	43034772	VCV003068533	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068533
20	43034772	VCV003068533	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068533
20	43042432	VCV003068532	TC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068532
20	43042345	VCV003068531	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV003068531
7	44191869	VCV003068513	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003068513
7	44184772	VCV003068512	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003068512
7	44190588	VCV003068510	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003068510
12	121416890	VCV003024563	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV003024563
7	44190586	VCV003024424	GAGA	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024424
7	44189624	VCV003024423	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024423
7	44190649	VCV003024422	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024422
7	44187429	VCV003024421	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024421
7	44187429	VCV003024420	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024420
7	44185202	VCV003024419	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024419
7	44185201	VCV003024418	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024418
7	44185190	VCV003024417	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024417
7	44184775	VCV003024416	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV003024416
12	121432022	VCV002758582	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002758582
12	121426807	VCV002746579	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002746579
7	44190673	VCV002735019	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002735019
7	44185160	VCV002734991	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002734991
7	44185160	VCV002734991	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002734991
7	44185114	VCV002734988	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002734988
12	121431493	VCV002691846	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691846
12	121431481	VCV002691845	CGA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691845
12	121431476	VCV002691844	A	AG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691844
12	121431470	VCV002691842	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691842
12	121426826	VCV002691838	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002691838
7	44189626	VCV002691829	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691829
7	44192995	VCV002691828	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691828
7	44189416	VCV002691827	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691827
7	44189408	VCV002691826	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691826
7	44185204	VCV002691825	CA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691825
7	44184827	VCV002691824	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691824
7	44184735	VCV002691823	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002691823
12	121431493	VCV002682654	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002682654
7	44191909	VCV002682653	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002682653
7	44192998	VCV002682651	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002682651
7	44190577	VCV002682650	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002682650
7	44189644	VCV002682649	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002682649
7	44185309	VCV002682417	TGCTTGCGGTC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002682417
7	44185216	VCV002664370	G	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664370
7	44186105	VCV002664366	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664366
7	44187289	VCV002664365	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664365
7	44189580	VCV002664364	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664364
7	44184823	VCV002664363	GTGATCTCGCAGC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664363
7	44186057	VCV002664362	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664362
7	44186061	VCV002664361	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664361
7	44186061	VCV002664360	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664360
7	44192999	VCV002664358	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002664358
7	44191883	VCV002662928	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002662928
7	44187423	VCV002628366	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002628366
7	44185217	VCV002628365	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002628365
7	44190573	VCV002628364	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002628364
7	44184881	VCV002628362	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002628362
7	44185175	VCV002581305	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002581305
20	43048424	VCV002581134	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002581134
7	44184875	VCV002581129	TGAAGCTGGGCAGAAGA	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002581129
7	44185109	VCV002581128	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002581128
7	44187288	VCV002581126	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002581126
7	44185205	VCV002581125	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002581125
7	44184811	VCV002581124	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002581124
12	121426669	VCV002581123	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002581123
12	121432032	VCV002581121	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002581121
12	121432032	VCV002581120	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002581120
20	43052894	VCV002580875	G	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002580875
20	43052894	VCV002580875	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002580875
7	44185238	VCV002578362	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578362
7	44184784	VCV002578361	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578361
7	44184769	VCV002578360	A	AC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578360
7	44185160	VCV002578359	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578359
7	44184785	VCV002578358	CCG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578358
7	44192998	VCV002578357	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578357
7	44190601	VCV002578355	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578355
7	44187337	VCV002578354	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578354
7	44187330	VCV002578353	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578353
7	44186197	VCV002578352	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578352
7	44184737	VCV002578351	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578351
7	44184735	VCV002578350	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578350
7	44186183	VCV002578349	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578349
7	44185228	VCV002578348	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578348
7	44185237	VCV002578347	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002578347
20	43034773	VCV002578345	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002578345
20	43043209	VCV002578341	A	AG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002578341
20	43052707	VCV002574172	G	GT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002574172
7	44185207	VCV002574163	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574163
7	44185174	VCV002574162	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574162
7	44184801	VCV002574161	G	GC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574161
7	44184880	VCV002574160	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574160
7	44184756	VCV002574159	CTTCT	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574159
7	44189645	VCV002574158	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574158
7	44189645	VCV002574157	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002574157
7	44184608	VCV002571664	GGCCTGGGTCCTGACAAGGCCAGGCCTCCTGCCCCGCCAGGCTGCGAGCACGTGTGGGGAGCACTTCCCCATGGAGCCTGGGTGCTGTGGGGCTGTGGCATCCTCCCTGCGCTTGCGGCCACTGCTCTCACTGGCCCAGCATACAGGCCTTCTTACAGGCCACCGCCG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571664
7	44184764	VCV002571663	AG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571663
7	44184764	VCV002571663	AG	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571663
7	44184764	VCV002571663	AG	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571663
7	44184764	VCV002571663	AG	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571663
7	44184880	VCV002571661	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571661
7	44184877	VCV002571658	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571658
7	44184871	VCV002571657	TC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571657
7	44184831	VCV002571654	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571654
7	44184815	VCV002571652	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571652
7	44184809	VCV002571651	C	CCGACT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571651
7	44184787	VCV002571650	GCGCCCCGGCCA	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571650
7	44184793	VCV002571649	C	CG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571649
7	44184789	VCV002571648	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571648
7	44184732	VCV002571647	CTCTCACTGGCCCAGCATACAGG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571647
7	44184770	VCV002571646	CCGCCGAGACCAGGGCCG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571646
7	44184860	VCV002571645	CATGGAACC	ATGAAGGTGGCTCGCA	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571645
7	44184741	VCV002571642	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002571642
7	44190580	VCV002567920	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002567920
20	43036100	VCV002505494	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002505494
7	44184740	VCV002505488	GGC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002505488
7	44191868	VCV002505487	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002505487
7	44189410	VCV002505486	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002505486
7	44189410	VCV002505485	TC	CT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002505485
7	44189629	VCV002503894	G	GCCTTGAAGC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002503894
20	43036074	VCV002502290	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002502290
20	43043303	VCV002502288	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002502288
7	44192001	VCV002500039	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002500039
7	44189563	VCV002431839	CT	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002431839
7	44189563	VCV002431839	CT	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002431839
7	44190601	VCV002428681	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002428681
7	44193063	VCV002136532	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV002136532
20	43052763	VCV002018786	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV002018786
12	121434088	VCV002010905	AC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV002010905
12	121426725	VCV001940407	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001940407
7	44192941	VCV001807279	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001807279
7	44184836	VCV001769182	TGG	CGGC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001769182
12	121431491	VCV001756327	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001756327
12	121426836	VCV001746441	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001746441
7	44189623	VCV001746350	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001746350
7	44190583	VCV001741488	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001741488
12	121426667	VCV001732973	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=VCV001732973
7	44185220	VCV001727652	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001727652
7	44184863	VCV001709730	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001709730
7	44184781	VCV001708917	AG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001708917
7	44190649	VCV001704126	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=VCV001704126
20	43052812	VCV001700663	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV001700663
20	43052864	VCV001700658	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=VCV001700658
12	121438883	rs2135854461T	TG	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=rs2135854461T
12	121426712	rs2135832632G	GA	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832632G
12	121426712	rs2135832632G	GA	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832632G
12	121431415	rs2135839346T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135839346T
12	121426706	rs2135832615G	GTGGTCGA	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832615G
12	121426685	rs2135832562C	CACA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832562C
12	121437379	rs2135851518G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135851518G
12	121437382	rs587778399GGCATCCAGCACC	AGCATCCAGCACCT	GGCATCCAGCACC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587778399GGCATCCAGCACC
12	121438938	rs2135854670C	CAA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=rs2135854670C
12	121438918	rs2135854597C	CAG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A,C12orf43;VARIANT_ID=rs2135854597C
12	121438900	rs2135854520T	TC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=rs2135854520T
12	121416700	rs2135819704A	CC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819704A
12	121435469	rs1131692182T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182T
12	121434372	rs2135845908CT	C	CT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135845908CT
12	121435473	rs1399164820C	G	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1399164820C
12	121426635	rs2135832426T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832426T
12	121426634	rs2135832423T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832423T
12	121438870	rs2135854397T	TCC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=rs2135854397T
7	44189623	rs2128821624G	C	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128821624G
7	44190563	rs1319364468C	T	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1319364468C
7	44187341	rs2128820597T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128820597T
12	121432067	rs1555212014A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212014A
12	121432114	rs762703502CG	C	CG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502CG
12	121432041	rs1057520504T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520504T
12	121432062	rs2135841855A	AC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841855A
12	121416692	rs2135819670T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819670T
12	121431491	rs2135839892TA	T	TA	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135839892TA
12	121416669	rs1001854457T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1001854457T
12	121426784	rs765432081G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs765432081G
12	121416852	rs2135820267CT	C	CT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820267CT
12	121416830	rs2135820197T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820197T
12	121416788	rs905788991T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs905788991T
12	121416773	rs2135819979C	CG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819979C
12	121416762	rs2135819929TG	T	TG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819929TG
12	121416756	rs2135819908A	AT	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819908A
12	121416754	rs2135819895C	CA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819895C
12	121416731	rs2135819834C	CGAGGG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819834C
12	121416648	rs2135819552C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819552C
12	121434372	rs371717826G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs371717826G
12	121416605	rs1275805852G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1275805852G
12	121416639	rs2135819527A	AAG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819527A
12	121416613	rs2135819438TG	GGCCCTGCTC	TG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819438TG
12	121416606	rs2135819422G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819422G
7	44191884	rs748554061G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs748554061G
7	44189644	rs2096278825A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096278825A
12	121426706	rs2135832611A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832611A
7	44185121	rs2128819136G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128819136G
12	121434372	rs371717826A	C	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs371717826A
12	121434372	rs371717826A	C	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs371717826A
12	121434372	rs371717826A	C	A	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs371717826A
12	121434372	rs371717826A	C	A	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs371717826A
20	43042366	rs2146412136T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146412136T
7	44186183	rs1255911887T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1255911887T
12	121426820	rs1057520291G	C	G	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520291G
12	121426820	rs1057520291G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057520291G
7	44184764	rs1339598338A	AGGCCACCGCCGAGACCAGGGCCGCGCCCC	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1339598338A
12	121426650	rs2135832474GT	G	GT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832474GT
12	121416653	rs2135819583T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819583T
12	121416588	rs2135819354A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819354A
12	121416587	rs2135819349T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819349T
12	121416572	rs193922592C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922592C
12	121432064	rs886039386G	C	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs886039386G
12	121432064	rs886039386G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs886039386G
12	121416898	rs2135820424T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820424T
12	121426724	rs1475566248T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1475566248T
12	121426836	rs1364708195C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1364708195C
12	121416590	rs2135819368CAGCTGCAGACGG	C	CAGCTGCAGACGG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135819368CAGCTGCAGACGG
12	121416891	rs2135820413C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135820413C
12	121434064	rs1565886545T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1565886545T
12	121426677	rs2135832538C	T	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832538C
12	121426677	rs2135832538C	T	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832538C
12	121432055	rs2135841769C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841769C
12	121432055	rs2135841769A	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841769A
12	121426733	rs2135832675T	TC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832675T
12	121416629	rs1249563793C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1249563793C
12	121416630	rs1566092362C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1566092362C
7	44184811	rs1286804191C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1286804191C
7	44184811	rs1286804191C	G	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1286804191C
12	121426770	rs2135832753C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135832753C
12	121438880	rs2135854451T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=rs2135854451T
7	44185177	rs2128819209T	TTGA	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128819209T
7	44184853	rs2128818859A	ACG	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128818859A
7	44184853	rs2128818859A	ACG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128818859A
20	42984444	rs2146127577C	CA	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146127577C
20	42984444	rs2146127577C	CA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs2146127577C
7	44185202	rs749298368G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs749298368G
7	44185204	rs2096271616T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096271616T
12	121431990	rs2135841238G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135841238G
7	44189378	rs142952813T	G	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs142952813T
7	44189378	rs142952813T	G	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs142952813T
7	44189378	rs142952813T	G	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs142952813T
7	44189378	rs142952813T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs142952813T
7	44185210	rs2128819280G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2128819280G
12	121416629	rs1249563793A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1249563793A
12	121416629	rs1249563793A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1249563793A
7	44187375	rs1583596522T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1583596522T
7	44187376	rs2096275721T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096275721T
7	44190584	rs2096280050G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096280050G
7	44186197	rs2096273902T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096273902T
12	121426697	rs1876669962T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1876669962T
7	44185200	rs2096271597C	CG	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096271597C
7	44185200	rs2096271597C	CG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096271597C
7	44185216	rs193929374C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929374C
7	44185219	rs193922264A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922264A
7	44184868	rs2096270755C	CGCTCCTTGAA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs2096270755C
12	121432117	rs1593058932CC	G	CC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1593058932CC
12	121432117	rs1593058932CC	G	CC	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1593058932CC
12	121432117	rs1593058932CC	G	CC	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1593058932CC
12	121432117	rs1593058932CC	G	CC	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1593058932CC
12	121432117	rs1593058932CC	G	CC	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1593058932CC
12	121432117	rs587776825G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587776825G
7	44187375	rs1583596522G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1583596522G
7	44184772	rs1583590393G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1583590393G
7	44185193	rs1583591700C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1583591700C
7	44185203	rs1583591809T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1583591809T
7	44185213	rs193922265A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922265A
7	44189416	rs1476637197T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1476637197T
7	44189416	rs1476637197T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1476637197T
20	42984446	rs1229650809C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1229650809C
7	44185236	rs556581174T	G	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs556581174T
7	44185236	rs556581174T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs556581174T
20	43043146	rs1568731279A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1568731279A
20	43043146	rs1568731279A	G	A	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1568731279A
20	43043146	rs1568731279A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1568731279A
20	43043146	rs1568731279A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1568731279A
12	121434064	rs1565886545A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1565886545A
12	121431422	rs1286294151A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1286294151A
12	121426679	rs1565883507T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1565883507T
20	43052763	rs1375557127A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1375557127A
20	43052763	rs1375557127A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1375557127A
20	43052763	rs1375557127A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1375557127A
7	44186129	rs193922340T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922340T
7	44186129	rs193922340T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922340T
7	44186129	rs193922340T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922340T
7	44187289	rs556436603A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs556436603A
7	44187289	rs556436603A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs556436603A
7	44187434	rs1562715657C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562715657C
7	44187434	rs1562715657C	T	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562715657C
7	44189430	rs1562717053G	A	G	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562717053G
7	44189430	rs1562717053G	A	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562717053G
7	44189430	rs1562717053G	A	G	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562717053G
7	44189430	rs1562717053G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562717053G
7	44190572	rs1562718043A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562718043A
7	44190674	rs1554335616C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335616C
7	44191911	rs193922292G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922292G
7	44192923	rs1444739794G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1444739794G
7	44184806	rs1562711915A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562711915A
7	44184823	rs1185622190A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1185622190A
7	44192981	rs1486280029A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1486280029A
7	44192981	rs1486280029A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1486280029A
7	44192981	rs1486280029A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1486280029A
7	44192981	rs1486280029A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1486280029A
7	44185175	rs1167124132A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1167124132A
7	44185175	rs1167124132A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1167124132A
7	44185220	rs1471992838A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1471992838A
7	44185294	rs1562713041A	AG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1562713041A
18	58039117	rs369841551A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=MC4R;VARIANT_ID=rs369841551A
11	17432091	rs761862121G	T	G	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ABCC8;VARIANT_ID=rs761862121G
11	17432091	rs761862121G	T	G	.	PASS	PHENOTYPE=DIABETES MELLITUS PERMANENT NEONATAL 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ABCC8;VARIANT_ID=rs761862121G
11	17409539	rs954727530A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=KCNJ11;VARIANT_ID=rs954727530A
11	17409539	rs954727530A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=KCNJ11;VARIANT_ID=rs954727530A
20	43034747	rs1555813267T	TG	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555813267T
7	44190667	rs1554335612A	T	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335612A
20	43034869	rs1555813342A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555813342A
20	43043218	rs1555815393A	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555815393A
12	121416572	rs193922592T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922592T
12	121435456	rs1555212396T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212396T
20	43043234	rs1555815396T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555815396T
12	121431972	rs1555211975AATGC	A	AATGC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211975AATGC
20	43048435	rs781364316T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs781364316T
20	43048411	rs1555816642C	CG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555816642C
20	43052798	rs1555817851C	CA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1555817851C
12	121432040	rs1555211999C	CGT	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211999C
12	121416573	rs1555260207T	TG	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555260207T
12	121426803	rs1555211436A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211436A
12	121426701	rs753998395T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs753998395T
12	121416899	rs1555210478G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555210478G
7	44186170	rs1554334894G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554334894G
7	44186198	rs1554334905T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554334905T
7	44187310	rs1554335111T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335111T
7	44187319	rs104894011T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894011T
7	44187319	rs104894011T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894011T
7	44187319	rs104894011T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894011T
7	44187331	rs104894008G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894008G
7	44187336	rs1554335132A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335132A
7	44187430	rs1332966015C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1332966015C
7	44189415	rs746913146A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs746913146A
7	44190574	rs1554335573G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335573G
7	44193064	rs1554335966C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335966C
7	44190668	rs759072800G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs759072800G
7	44185114	rs1554334539C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554334539C
7	44185120	rs1554334546T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554334546T
7	44185193	rs1400535021GC	G	GC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1400535021GC
7	44185205	rs1554334613G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554334613G
7	44185207	rs193922266T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922266T
7	44185207	rs193922266T	A	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922266T
7	44185207	rs193922266T	A	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922266T
7	44185207	rs193922266T	A	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922266T
7	44185213	rs193922265C	G	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922265C
7	44185199	rs1554334610C	CCGAGCACATGTGCGCAG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554334610C
7	44185229	rs1415041911T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1415041911T
7	44185330	rs193922258T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922258T
12	121438916	rs1555212747GC	G	GC	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=C12orf43,HNF1A;VARIANT_ID=rs1555212747GC
20	43052772	rs776489992AGCT	A	AGCT	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs776489992AGCT
20	43052772	rs776489992AGCT	A	AGCT	.	PASS	PHENOTYPE=DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs776489992AGCT
20	43052772	rs776489992AGCT	A	AGCT	.	PASS	PHENOTYPE=FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs776489992AGCT
20	43052772	rs776489992AGCT	A	AGCT	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs776489992AGCT
20	43052772	rs776489992AGCT	A	AGCT	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs776489992AGCT
20	43052772	rs776489992AGCT	A	AGCT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs776489992AGCT
20	43043187	rs1280663753C	CGAA	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1280663753C
12	121431471	rs1555211927C	CAAG	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555211927C
12	121435325	rs1555212359G	GC	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212359G
12	121435325	rs1555212359G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212359G
12	121434372	rs1555212248C	CT	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212248C
12	121434372	rs1555212248C	CT	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212248C
12	121434372	rs1555212248C	CT	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1555212248C
12	121432114	rs762703502C	CG	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502C
12	121432114	rs762703502C	CG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502C
12	121432114	rs762703502C	CG	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502C
12	121432114	rs762703502C	CG	C	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502C
12	121432114	rs762703502C	CG	C	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502C
12	121432114	rs762703502C	CG	C	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs762703502C
7	44187363	rs370375148T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs370375148T
7	44187288	rs767565869A	C	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs767565869A
7	44187288	rs767565869A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs767565869A
7	44190674	rs1554335616T	G	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335616T
7	44190674	rs1554335616T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335616T
7	44189371	rs1360415315T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1360415315T
7	44189371	rs1360415315T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1360415315T
7	44189371	rs1360415315T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1360415315T
7	44189371	rs1360415315T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1360415315T
7	44187337	rs1375656631T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1375656631T
7	44187337	rs1375656631T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1375656631T
7	44184811	rs1286804191A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1286804191A
11	17428605	rs769518471A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ABCC8;VARIANT_ID=rs769518471A
7	44189581	rs1554335441G	A	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335441G
7	44189581	rs1554335441G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1554335441G
12	121435469	rs1131692182A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182A
12	121435469	rs1131692182A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182A
12	121435469	rs1131692182A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182A
12	121435469	rs1131692182A	G	A	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182A
12	121435469	rs1131692182A	G	A	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182A
12	121435469	rs1131692182A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1131692182A
20	43052757	rs369429452A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs369429452A
20	43052757	rs369429452A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs369429452A
7	44184793	rs1064795242C	CG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064795242C
7	44192995	rs1064794268G	T	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064794268G
7	44192995	rs1064794268G	T	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064794268G
7	44192924	rs1064793998T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064793998T
7	44192924	rs1064793998T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064793998T
7	44192924	rs1064793998T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064793998T
7	44192924	rs1064793998T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1064793998T
7	44192937	rs1057520109T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057520109T
20	43047122	rs1060499693A	T	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1060499693A
12	121431489	rs1057524908GC	G	GC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1057524908GC
11	2181137	rs1057524907C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=INS,INS-IGF2;VARIANT_ID=rs1057524907C
7	44192986	rs1057524906G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524906G
7	44187433	rs1057524905T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524905T
7	44187433	rs1057524905T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524905T
7	44187364	rs1057524904A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524904A
7	44187364	rs1057524904A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524904A
7	44187364	rs1057524904A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524904A
7	44187364	rs1057524904A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524904A
7	44187364	rs1057524904A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524904A
7	44186065	rs1057524903C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524903C
7	44185094	rs1057524902T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524902T
7	44185094	rs1057524902T	A	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524902T
7	44184788	rs1057524901C	CG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524901C
7	44184772	rs1057524900T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057524900T
4	6303575	rs112967046T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=WFS1;VARIANT_ID=rs112967046T
20	43034874	rs1057524790C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1057524790C
20	43034874	rs1057524790C	T	C	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1057524790C
7	44185250	rs1057521092T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057521092T
7	44192937	rs1057520109A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs1057520109A
20	43034836	rs1057517745A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1057517745A
7	44185201	rs777870079A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs777870079A
7	44185201	rs777870079A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs777870079A
7	44185201	rs777870079A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs777870079A
7	44185201	rs777870079A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs777870079A
4	6303716	rs71526458T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=WFS1;VARIANT_ID=rs71526458T
7	44190668	rs759072800T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs759072800T
7	44187424	rs794727839G	A	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727839G
7	44187424	rs794727839G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727839G
7	44189437	rs794727775A	C	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727775A
7	44189437	rs794727775A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727775A
7	44192990	rs794727236T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727236T
7	44192990	rs794727236T	C	T	.	PASS	PHENOTYPE=DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727236T
7	44192990	rs794727236T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727236T
7	44192990	rs794727236T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs794727236T
7	44190589	rs193922297T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922297T
7	44185237	rs587780343A	C	A	.	PASS	PHENOTYPE=GESTATIONAL DIABETES;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780343A
7	44185237	rs587780343A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs587780343A
1	156105800	rs267607555T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LMNA;VARIANT_ID=rs267607555T
4	6303342	rs373862003T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=WFS1;VARIANT_ID=rs373862003T
7	44186066	rs397514580T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs397514580T
12	121432080	rs137853245G	C	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853245G
12	121432080	rs137853245G	C	G	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853245G
12	121432080	rs137853245G	C	G	.	PASS	PHENOTYPE=TYPE 1 DIABETES MELLITUS 20;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853245G
12	121432080	rs137853245G	C	G	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs137853245G
12	121432056	rs193922605C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922605C
12	121431466	rs193922600T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922600T
12	121431457	rs193922599C	CAGA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922599C
12	121426822	rs386134267A	AGAGGTGGCGCAGCGTAAGTAATGACCCTACCCCGCATCTTCCCTGG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs386134267A
12	121426677	rs193922596TGCA	T	TGCA	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922596TGCA
12	121416882	rs193922594TG	T	TG	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922594TG
12	121416572	rs193922592G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922592G
12	121416739	rs193922588G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922588G
12	121437072	rs193922582CCT	C	CCT	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922582CCT
12	121416696	rs193922578G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922578G
12	121434360	rs193922576G	GC	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs193922576G
20	43052762	rs193922480T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs193922480T
20	43047142	rs193922476TCAA	GCT	TCAA	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs193922476TCAA
20	43043291	rs193922475C	CTGGACGACCAGGTGAGGA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs193922475C
20	43036077	rs193922471C	GG	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs193922471C
7	44186210	rs193922335A	T	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922335A
7	44186210	rs193922335A	T	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922335A
7	44186210	rs193922335A	T	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922335A
7	44189361	rs193922319G	A	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922319G
7	44189361	rs193922319G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922319G
7	44189377	rs193922317T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922317T
7	44189380	rs193922315G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922315G
7	44189408	rs193922313A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922313A
7	44189433	rs193922311G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922311G
7	44190555	rs193922302T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922302T
7	44190581	rs193922300A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922300A
7	44190581	rs193922300A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922300A
7	44190589	rs193922297G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922297G
7	44190589	rs193922297G	A	G	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922297G
7	44191929	rs193922291A	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922291A
7	44192019	rs193922289T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922289T
7	44192019	rs193922289T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922289T
7	44192019	rs193922289T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922289T
7	44192962	rs193922286T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922286T
7	44184759	rs193922284C	CTT	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922284C
7	44184775	rs193922283A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922283A
7	44184775	rs193922283A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922283A
7	44184775	rs193922283A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922283A
7	44184788	rs193922282T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922282T
7	44184800	rs193922280T	TG	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922280T
7	44184826	rs193922278T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922278T
7	44184848	rs193922275T	TGC	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922275T
7	44185109	rs193922272C	T	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922272C
7	44185109	rs193922272C	T	C	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922272C
7	44185174	rs193922269A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922269A
7	44185189	rs193921338T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193921338T
7	44185192	rs193922268G	A	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922268G
7	44185207	rs193922266C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922266C
7	44185213	rs193922265T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922265T
7	44185219	rs193922264T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922264T
7	44185225	rs193922263A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922263A
7	44185235	rs193922262A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922262A
7	44185307	rs193922260A	T	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922260A
7	44185330	rs193922258G	C	G	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922258G
7	44185339	rs193922257T	G	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193922257T
7	44187322	rs193929373T	C	T	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929373T
7	44187322	rs193929373T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929373T
7	44187322	rs193929373T	C	T	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929373T
7	44187322	rs193929373T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929373T
7	44185159	rs193929375A	C	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929375A
7	44185216	rs193929374A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929374A
7	44186060	rs193929376C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs193929376C
7	44185217	rs104894016T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894016T
7	44189409	rs80356654T	A	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654T
7	44189409	rs80356654T	A	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654T
7	44189409	rs80356654T	A	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356654T
7	44187331	rs104894008T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894008T
7	44187331	rs104894008T	C	T	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894008T
7	44187331	rs104894008T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894008T
7	44187331	rs104894008T	C	T	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs104894008T
7	44187429	rs80356655A	G	A	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 2;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356655A
7	44187429	rs80356655A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS 1;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356655A
7	44187429	rs80356655A	G	A	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356655A
7	44187429	rs80356655A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356655A
7	44187429	rs80356655A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=GCK;VARIANT_ID=rs80356655A
12	121416708	rs1566092470A	AG	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs1566092470A
12	121416289	rs2135818776C	A	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs2135818776C
12	121432117	rs587776825GC	G	GC	.	PASS	PHENOTYPE=MATURITY-ONSET DIABETES OF THE YOUNG TYPE 3;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587776825GC
12	121432117	rs587776825GC	G	GC	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587776825GC
12	121432117	rs587776825GC	G	GC	.	PASS	PHENOTYPE=DIABETES MELLITUS TYPE 1;INTERPRETATION=TO FOLLOW UP;INTERPRETATION_REASON=Follow this variant to check if the assertion criteria is provided by the scientific community in a near future;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587776825GC
12	121432117	rs587776825GC	G	GC	.	PASS	PHENOTYPE=MATURITY ONSET DIABETES MELLITUS IN YOUNG;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF1A;VARIANT_ID=rs587776825GC
1	156106776	rs11575937A	G	A	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LMNA;VARIANT_ID=rs11575937A
1	156106776	rs11575937A	G	A	.	PASS	PHENOTYPE=TYPE 2 DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=LMNA;VARIANT_ID=rs11575937A
20	43047062	rs1600731198C	CA	C	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs1600731198C
20	43048453	rs137853334T	C	T	.	PASS	PHENOTYPE=MONOGENIC DIABETES;INTERPRETATION=ACCEPTED WITH STRONG EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable by an expert panel or a practice guideline;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=HNF4A;VARIANT_ID=rs137853334T
11	17417462	rs137852673A	G	A	.	PASS	PHENOTYPE=PERMANENT NEONATAL DIABETES MELLITUS;INTERPRETATION=ACCEPTED WITH MODERATE EVIDENCE;INTERPRETATION_REASON=The variant has been interpreted as clinically actionable using the ACMG/AMP guidelines;CLINICAL_ACTIONABILITY=Disorder causing or risk factor;GENE=ABCC8;VARIANT_ID=rs137852673A
